Read this topic

A fresh doctor might expect a field as evidence-based as psychiatry to have shed old names in favour of plain descriptive terms. It largely has for diagnostic labels, but the EPONYMS (terms named after the person credited with first describing a phenomenon) survive everywhere in clinical language and exam questions, because they compress a whole clinical picture into a single memorable name. Hold that compression idea through every section below: each eponym is really shorthand for a specific, learnable pattern.

An eponym in psychiatry is a sign, syndrome, or scale named after the clinician or researcher who first described it, rather than a term built from its features (a descriptive term). Learning the history behind the name is not trivia for its own sake; it usually reveals WHY the sign was considered clinically distinctive at the time, which helps distinguish it from similar-sounding modern descriptive terms.

A common mistake is assuming an eponym always maps cleanly onto a single modern diagnostic category. Many eponymous descriptions predate ICD and DSM criteria and describe a narrower or differently-bounded phenomenon than the modern category that superficially resembles it; for example, Kraepelin's dementia praecox is the historical ancestor of schizophrenia but was not defined using today's symptom-based criteria. Treat eponyms as historically important descriptive shorthand, not as interchangeable synonyms for current diagnostic terms.

Imagine a nineteenth-century clinician seeing a genuinely new clinical pattern for the first time, with no existing name for it. The natural move was to describe it in a paper and let it become known by the describer's own name, since a shared descriptive vocabulary did not yet exist. Emil Kraepelin, a German psychiatrist working in the late nineteenth and early twentieth centuries, is credited with separating what we now recognise as schizophrenia (which he termed dementia praecox) from bipolar disorder (which he termed manic-depressive insanity), based on differences in course and outcome rather than symptoms alone: an early example of classification by longitudinal pattern rather than a single snapshot. Eugen Bleuler, a Swiss psychiatrist, coined the actual term "schizophrenia" and described his own set of core features, sometimes remembered as Bleuler's four As: association (loosening), affect (blunting), ambivalence, and autism (social withdrawal), a different emphasis from the positive symptoms (hallucinations, delusions) that dominate modern criteria.

Karl Jaspers, a German philosopher-psychiatrist, contributed the distinction between UNDERSTANDABLE (a reaction that follows logically from a patient's situation or mood) and UN-UNDERSTANDABLE mental phenomena, underpinning the modern primary/secondary delusion split. Capgras syndrome (named after Joseph Capgras) is the belief that a familiar person has been replaced by an impostor; imagine a patient convinced their spouse looks identical but is secretly someone else, and that vivid, specific picture is exactly what makes an eponym easier to recall than a purely descriptive label like "delusional misidentification of person." Cotard's syndrome (named after Jules Cotard) is the nihilistic delusion that one is dead, does not exist, or is rotting internally. Charles Bonnet syndrome describes vivid, complex visual hallucinations occurring in people with significant visual impairment but intact insight and no other psychotic features, a useful example because the eponym signals "not psychosis," which a purely descriptive label might obscure.

Many widely used clinical instruments are also eponymous. The Hamilton Rating Scale for Depression (named after Max Hamilton) and the Montgomery-Åsberg Depression Rating Scale (MADRS, named after its two creators) are clinician-administered depression severity scales; the Mini-Mental State Examination, though not itself named after a person, sits alongside eponymous cognitive tools such as the Folstein test (its common informal name, after its creators Marshal and Susan Folstein). Recognising that a scale's eponym and its descriptive purpose refer to the same instrument avoids confusion when a vignette uses one name and a question stem uses the other.

Distractors frequently pair the wrong name with the wrong syndrome, so keep the eponyms that sound alike clearly separated. Capgras syndrome (an impostor has replaced a familiar person) is not Fregoli syndrome (a stranger is believed to be a familiar person in disguise): the two are opposite in direction and are a classic exam swap. Cotard's syndrome (belief of being dead or non-existent) is not the same as a straightforward severe nihilistic depressive delusion without the specific "I am dead, I am rotting" content. Bleuler's four As describe schizophrenia's core features as HE defined them and should not be attributed to Kraepelin, who instead is remembered for the course-based split between dementia praecox and manic-depressive insanity. Modern classification, for example ICD-11's move toward purely descriptive category names, increasingly avoids introducing NEW eponyms, partly because they can obscure meaning for learners unfamiliar with the history, and partly out of sensitivity where an eponym honours a historical figure with a troubling record.

There is no laboratory test for an eponym; "diagnosing" one is really a pattern-matching exercise. Faced with a vignette, the reader strips away the specific eponymous label and asks what the underlying clinical picture actually is, then checks whether that picture matches the ONE feature that made a particular name historically distinctive: a familiar person replaced by an impostor points to Capgras; a belief of being already dead points to Cotard; vivid visual hallucinations with preserved insight in a visually impaired patient points to Charles Bonnet. This is the same skill a clinician uses in real practice when a patient's own words echo a classic historical description, and it is exactly the skill exam questions are testing when they hide the name and ask for it, or state the name and ask for the definition.

In modern clinical practice, eponyms are used as efficient shorthand in conversation and teaching between clinicians who already share the background knowledge, but formal documentation and diagnostic coding increasingly favour the descriptive ICD-11 term instead, precisely because a descriptive term does not depend on the reader already knowing the history. The practical approach is therefore bilingual: know the eponym for rapid recognition and communication, but be able to translate it fluently into its modern descriptive equivalent for notes, coding, and patient-facing explanation. For exam and clinical practice alike, the most useful way to manage this body of knowledge is to anchor each eponym to the single feature that made it distinctive, rather than trying to memorise names as an isolated list.

Questions sometimes present the eponym and expect the descriptive definition, or vice versa, and distractors frequently pair the wrong name with the wrong syndrome, for example swapping Capgras and Fregoli, or attributing Bleuler's four As to Kraepelin. Anchor each name to the ONE feature that made it historically distinctive rather than trying to memorise names in isolation.

Psychiatric eponyms: Kraepelin's classification split, Bleuler's four As, Jaspers's understandable/un-understandable distinction, Capgras and Cotard syndromes, Charles Bonnet syndrome, and eponymous scales like Hamilton's: are shorthand for specific historical descriptions, recognised by matching a vignette to the one feature that made each name distinctive, and used in practice as efficient spoken shorthand that should still be translated into a modern descriptive term for formal records.